Table 3.
Variables | Before TRT |
6 months after TRT |
||||||
---|---|---|---|---|---|---|---|---|
Univariate analysis |
Multivariate analysis |
Univariate analysis |
Multivariate analysis |
|||||
OR | p | OR | p | OR | p | OR | p | |
Age | 1.012 | .656 | — | — | ||||
BMI | 2.040 | .179 | 2.314 | .114 | ||||
AMS score | 4.059 | .021 | 4.099 | .025 | 1.190 | .775 | ||
IIEF-5 | 1.385 | .567 | 3.235 | .043 | 7.922 | .013 | ||
Residual urine volume | 1.004 | .773 | 1.007 | .710 | ||||
Prostate volume | 3.235 | .043 | 3.272 | .051 | 3.600 | .049 | 8.275 | .014 |
PSA | 0.793 | .707 | 0.716 | .445 | ||||
Total testosterone | 1.004 | .978 | 1.009 | .880 | ||||
Free testosterone | 1.054 | .631 | 1.018 | .525 |
Note. BMI = body mass index; IPSS = International Prostate Symptom Score; TRT = testosterone replacement therapy; AMS = Aging Male Symptoms; IIEF-5 = International Index of Erectile Function–5; PSA = prostate-specific antigen. Cutoff level of each variable was determined based on its median value in 60 patients included in this study.